KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
E. The absence of wheezes
A 26-year-old male with
asthma is seen in the
emergency department. He is
short of breath to a degree that
makes it difficult to speak in
sentences and he appears
tired. On examination you
note diminished breath sounds
with an occasional wheeze.
His FEV1 is 15% of predicted
and his pCO2 is 45 mm Hg.
He is given albuterol
(Proventil, Ventolin) over the
next hour but he has a poor
response. He is not able to
repeat the spirometry and he
now appears drowsy. Which
one of the following would be
consistent with imminent
respiratory failure?
D. They are less effective than inhaled corticosteroids (ICSs)
Which one of the following is
true regarding leukotriene
modifiers for treatment of
asthma in adults?
E. no long-term adverse effects
Chronic low- to medium-dose
inhaled corticosteroid use in
children is associated with
2025/11/10
, KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
A. Budesonide/formoterol (Symbicort), with an increase in
dosage for exacerbations
An 18-year-old female
presents to your office with a
history of wheezing,
coughing, and year-round
symptoms of rhinitis. She
reports that her symptoms
occur several times a week
but rarely more than once a
day, except in the last year,
when she has had to
intermittently use albuterol
(Proventil, Ventolin) every
day for a week at a time. She
wakes up with nighttime
coughing weekly, with no
fever or other symptoms, and
tells you that the coughing is
severe enough to make her cat
jump off the bed. Albuterol
helps her symptoms
temporarily. She has been
treated with oral
corticosteroids on three
occasions this past year, most
recently 6 weeks ago. Her
Asthma Control Test score is
17. Pre- and
postbronchodilator spirometry
results are shown below.
Initial testing
FVC............2.0 L (80% of
predicted)
FEV1............1.4 L (70% of
predicted)
FEF 25-75............1.5 L/sec
(89% of predicted)
15 minutes post
bronchodilator
2025/11/10
,KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
2025/11/10
, KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
C. A PEF of 310 L/min
A 22-year-old female presents
to your office with an acute
asthma attack that developed
2 days after the onset of a
viral upper respiratory
infection. Her asthma is
usually well controlled, with a
personal best peak expiratory
flow (PEF) of 380 L/min. On
initial evaluation by the nurse
she has a pulse rate of 120
beats/min, a respiratory rate
of 32/min, and an oxygen
saturation of 92% on room air.
On examination she is very
dyspneic with diffuse
inspiratory and expiratory
wheezing and she is using
accessory muscles to breathe.
Her PEF is 150 L/min.
Inhaled β-agonists and
systemic corticosteroids are
administered and she is
reevaluated 1 hour later.
Which one of the following
would provide the most
reassurance that she is
responding to therapy?
2025/11/10
E. The absence of wheezes
A 26-year-old male with
asthma is seen in the
emergency department. He is
short of breath to a degree that
makes it difficult to speak in
sentences and he appears
tired. On examination you
note diminished breath sounds
with an occasional wheeze.
His FEV1 is 15% of predicted
and his pCO2 is 45 mm Hg.
He is given albuterol
(Proventil, Ventolin) over the
next hour but he has a poor
response. He is not able to
repeat the spirometry and he
now appears drowsy. Which
one of the following would be
consistent with imminent
respiratory failure?
D. They are less effective than inhaled corticosteroids (ICSs)
Which one of the following is
true regarding leukotriene
modifiers for treatment of
asthma in adults?
E. no long-term adverse effects
Chronic low- to medium-dose
inhaled corticosteroid use in
children is associated with
2025/11/10
, KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
A. Budesonide/formoterol (Symbicort), with an increase in
dosage for exacerbations
An 18-year-old female
presents to your office with a
history of wheezing,
coughing, and year-round
symptoms of rhinitis. She
reports that her symptoms
occur several times a week
but rarely more than once a
day, except in the last year,
when she has had to
intermittently use albuterol
(Proventil, Ventolin) every
day for a week at a time. She
wakes up with nighttime
coughing weekly, with no
fever or other symptoms, and
tells you that the coughing is
severe enough to make her cat
jump off the bed. Albuterol
helps her symptoms
temporarily. She has been
treated with oral
corticosteroids on three
occasions this past year, most
recently 6 weeks ago. Her
Asthma Control Test score is
17. Pre- and
postbronchodilator spirometry
results are shown below.
Initial testing
FVC............2.0 L (80% of
predicted)
FEV1............1.4 L (70% of
predicted)
FEF 25-75............1.5 L/sec
(89% of predicted)
15 minutes post
bronchodilator
2025/11/10
,KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
2025/11/10
, KSA Asthma Study Set 2025/2026 ? Practice Questions & Verified Answers
C. A PEF of 310 L/min
A 22-year-old female presents
to your office with an acute
asthma attack that developed
2 days after the onset of a
viral upper respiratory
infection. Her asthma is
usually well controlled, with a
personal best peak expiratory
flow (PEF) of 380 L/min. On
initial evaluation by the nurse
she has a pulse rate of 120
beats/min, a respiratory rate
of 32/min, and an oxygen
saturation of 92% on room air.
On examination she is very
dyspneic with diffuse
inspiratory and expiratory
wheezing and she is using
accessory muscles to breathe.
Her PEF is 150 L/min.
Inhaled β-agonists and
systemic corticosteroids are
administered and she is
reevaluated 1 hour later.
Which one of the following
would provide the most
reassurance that she is
responding to therapy?
2025/11/10
